These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 10715453

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine.
    Satterthwaite R, Aswad S, Sunga V, Shidban H, Bogaard T, Asai P, Khetan U, Akra I, Mendez RG, Mendez R.
    Transplantation; 1998 Feb 15; 65(3):446-9. PubMed ID: 9484771
    [Abstract] [Full Text] [Related]

  • 4. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G, Tarantino A, Aroldi A, Banfi G, Cesana B, Ponticelli C.
    Transplant Proc; 1994 Oct 15; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract] [Full Text] [Related]

  • 5. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
    Copley JB, Staffeld C, Lindberg J, Hansen A, Bailey C, Anand R, Van Veldhuisen P.
    Transplant Proc; 1998 Jun 15; 30(4):1254-6. PubMed ID: 9636510
    [No Abstract] [Full Text] [Related]

  • 6. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
    Pohanka E, Margreiter R, Sparacino V, Sperschneider H, European Switch to Tacrolimus Study Group.
    Transplant Proc; 2005 May 15; 37(4):1874-6. PubMed ID: 15919490
    [Abstract] [Full Text] [Related]

  • 7. Effects of fish oil in cyclosporine-treated renal transplant recipients.
    Santos J, Queirós J, Silva F, Cabrita A, Rodrigues A, Henriques AC, Sarmento AM, Pereira MC, Guimarães S.
    Transplant Proc; 2000 Dec 15; 32(8):2605-8. PubMed ID: 11134724
    [No Abstract] [Full Text] [Related]

  • 8. Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.
    McCune TR, Thacker LR II, Peters TG, Mulloy L, Rohr MS, Adams PA, Yium J, Light JA, Pruett T, Gaber AO, Selman SH, Jonsson J, Hayes JM, Wright FH, Armata T, Blanton J, Burdick JF.
    Transplantation; 1998 Jan 15; 65(1):87-92. PubMed ID: 9448150
    [Abstract] [Full Text] [Related]

  • 9. Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report.
    Jurewicz WA.
    Transplant Proc; 1999 Nov 15; 31(7A):64S-66S. PubMed ID: 10576048
    [No Abstract] [Full Text] [Related]

  • 10. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S, Garrigue V, Delmas S, Chong G, Swarcz I, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep 15; 38(7):2311-3. PubMed ID: 16980075
    [Abstract] [Full Text] [Related]

  • 11. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S, Garrigue V, Dupuy AM, Chong G, Cristol JP, Mourad G.
    Transplant Proc; 2006 Sep 15; 38(7):2314-6. PubMed ID: 16980076
    [Abstract] [Full Text] [Related]

  • 12. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
    Colak T, Karakayali H, Yagmurdur MC, Moray G.
    Transplant Proc; 2002 Sep 15; 34(6):2081-2. PubMed ID: 12270321
    [No Abstract] [Full Text] [Related]

  • 13. Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients.
    Caillard S, Leray C, Kunz K, Gachet C, Offner M, Wiesel ML, Hannedouchte T, Cazenave JP, Moulin B.
    Transplant Proc; 2000 Dec 15; 32(8):2787-8. PubMed ID: 11134806
    [No Abstract] [Full Text] [Related]

  • 14. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
    Kohnle M, Zimmermann U, Lütkes P, Albrecht KH, Philipp T, Heemann U.
    Transpl Int; 2000 Dec 15; 13 Suppl 1():S345-8. PubMed ID: 11112029
    [Abstract] [Full Text] [Related]

  • 15. Effect of pravastatin on renal transplant recipients treated with cyclosporine--4-year follow-up.
    Yoshimura N, Ohmori Y, Tsuji T, Oka T.
    Transplant Proc; 1994 Oct 15; 26(5):2632-3. PubMed ID: 7940820
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
    Baid-Agrawal S, Delmonico FL, Tolkoff-Rubin NE, Farrell M, Williams WW, Shih V, Auchincloss H, Cosimi AB, Pascual M.
    Transplantation; 2004 Apr 27; 77(8):1199-202. PubMed ID: 15114085
    [Abstract] [Full Text] [Related]

  • 17. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
    Artz MA, Boots JM, Ligtenberg G, Roodnat JI, Christiaans MH, Hené RJ, Blom HJ, Demacker PN, Hilbrands LB.
    Transplant Proc; 2002 Aug 27; 34(5):1793-4. PubMed ID: 12176579
    [No Abstract] [Full Text] [Related]

  • 18. Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin.
    Skalicka B, Kubanek M, Malek I, Vymetalova Y, Hoskova L, Podzimkova M, Kautzner J.
    J Heart Lung Transplant; 2009 Jun 27; 28(6):598-604. PubMed ID: 19481021
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of morphological characteristics of renal injuries of tacrolimus (FK506) and cyclosporin (CyA) in renal allografts: are the morphologic characteristics of FK506 and CyA nephrotoxicity similar?
    Morozumi K, Sugito K, Oda A, Takeuchi O, Fukuda M, Usami T, Oikawa T, Fujinami T, Koyama K, Takeda A, Yoshida A, Haba T, Tominaga Y, Uchida K, Yokoyama I, Takagi H.
    Transplant Proc; 1996 Apr 27; 28(2):1076-8. PubMed ID: 8623232
    [No Abstract] [Full Text] [Related]

  • 20. Long-term follow-up after conversion from tacrolimus to cyclosporin in renal transplant patients with new-onset diabetes mellitus after transplantation.
    Batista F, Auyanet I, Torregrosa JV, Oppenheimer F.
    Transplant Proc; 2012 Nov 27; 44(9):2582-4. PubMed ID: 23146461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.